Nuclear Medicine Market Report

Global and Regional Nuclear Medicine Market Details Research Report 2021-2026

  • POSTDATE：Jun 29, 2021
  • PAGES：219
  • REPORT CODE：GMM745728
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Nuclear Medicine Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Nuclear Medicine market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Nuclear Medicine market.

    By Player:

    • Yantai Dongcheng Biochemicals

    • GE Healthcare

    • Jubilant Pharma

    • Eli Lilly

    • Mallinckrodt

    • China Isotope & Radiation

    • Bracco Imaging

    • Nordion

    • Lantheus Medical Imaging

    • SIEMENS

    • Bayer

    By Type:

    • Tc-99

    • I-123/131

    • In-111

    • Xe-133

    • Th-201

    • Ga-67

    • Other

    By End-User:

    • Diagnostic

    • Therapeutic

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Nuclear Medicine Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Nuclear Medicine Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Nuclear Medicine Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Nuclear Medicine Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Nuclear Medicine Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Nuclear Medicine Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Yantai Dongcheng Biochemicals

      • 3.1.1 Yantai Dongcheng Biochemicals - Company Business Overview

      • 3.1.2 Yantai Dongcheng Biochemicals - Company Financial Performance

      • 3.1.3 Yantai Dongcheng Biochemicals - Company Financial Performance of Nuclear Medicine

      • 3.1.4 Nuclear Medicine Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 GE Healthcare

      • 3.2.1 GE Healthcare - Company Business Overview

      • 3.2.2 GE Healthcare - Company Financial Performance

      • 3.2.3 GE Healthcare - Company Financial Performance of Nuclear Medicine

      • 3.2.4 Nuclear Medicine Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Jubilant Pharma

      • 3.3.1 Jubilant Pharma - Company Business Overview

      • 3.3.2 Jubilant Pharma - Company Financial Performance

      • 3.3.3 Jubilant Pharma - Company Financial Performance of Nuclear Medicine

      • 3.3.4 Nuclear Medicine Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Eli Lilly

      • 3.4.1 Eli Lilly - Company Business Overview

      • 3.4.2 Eli Lilly - Company Financial Performance

      • 3.4.3 Eli Lilly - Company Financial Performance of Nuclear Medicine

      • 3.4.4 Nuclear Medicine Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Mallinckrodt

      • 3.5.1 Mallinckrodt - Company Business Overview

      • 3.5.2 Mallinckrodt - Company Financial Performance

      • 3.5.3 Mallinckrodt - Company Financial Performance of Nuclear Medicine

      • 3.5.4 Nuclear Medicine Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 China Isotope & Radiation

      • 3.6.1 China Isotope & Radiation - Company Business Overview

      • 3.6.2 China Isotope & Radiation - Company Financial Performance

      • 3.6.3 China Isotope & Radiation - Company Financial Performance of Nuclear Medicine

      • 3.6.4 Nuclear Medicine Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Bracco Imaging

      • 3.7.1 Bracco Imaging - Company Business Overview

      • 3.7.2 Bracco Imaging - Company Financial Performance

      • 3.7.3 Bracco Imaging - Company Financial Performance of Nuclear Medicine

      • 3.7.4 Nuclear Medicine Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Nordion

      • 3.8.1 Nordion - Company Business Overview

      • 3.8.2 Nordion - Company Financial Performance

      • 3.8.3 Nordion - Company Financial Performance of Nuclear Medicine

      • 3.8.4 Nuclear Medicine Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Lantheus Medical Imaging

      • 3.9.1 Lantheus Medical Imaging - Company Business Overview

      • 3.9.2 Lantheus Medical Imaging - Company Financial Performance

      • 3.9.3 Lantheus Medical Imaging - Company Financial Performance of Nuclear Medicine

      • 3.9.4 Nuclear Medicine Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 SIEMENS

      • 3.10.1 SIEMENS - Company Business Overview

      • 3.10.2 SIEMENS - Company Financial Performance

      • 3.10.3 SIEMENS - Company Financial Performance of Nuclear Medicine

      • 3.10.4 Nuclear Medicine Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Bayer

      • 3.11.1 Bayer - Company Business Overview

      • 3.11.2 Bayer - Company Financial Performance

      • 3.11.3 Bayer - Company Financial Performance of Nuclear Medicine

      • 3.11.4 Nuclear Medicine Product Benchmarking

      • 3.11.5 Strategic Initiatives

    4 Global Nuclear Medicine Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Nuclear Medicine Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Tc-99 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of I-123/131 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of In-111 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Xe-133 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Th-201 2016-2021

      • 4.2.6 Global Revenue and Growth Rate of Ga-67 2016-2021

      • 4.2.7 Global Revenue and Growth Rate of Other 2016-2021

    • 4.3 Global Nuclear Medicine Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Tc-99 2016-2021

      • 4.3.2 Global Sales and Growth Rate of I-123/131 2016-2021

      • 4.3.3 Global Sales and Growth Rate of In-111 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Xe-133 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Th-201 2016-2021

      • 4.3.6 Global Sales and Growth Rate of Ga-67 2016-2021

      • 4.3.7 Global Sales and Growth Rate of Other 2016-2021

    • 4.4 Global Nuclear Medicine Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Nuclear Medicine Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Nuclear Medicine Market Price By Type from 2016 to 2026

    5 Global Nuclear Medicine Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Nuclear Medicine

    • 5.2 Global Nuclear Medicine Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Diagnostic 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Therapeutic 2016-2021

    • 5.3 Global Nuclear Medicine Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Diagnostic 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Therapeutic 2016-2021

    • 5.4 Global Nuclear Medicine Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Nuclear Medicine Market Sales and Market Share by Application (Forecast)

    6 Global Nuclear Medicine Market Segment Analysis (Geography Level)

    • 6.1 Global Nuclear Medicine Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Nuclear Medicine Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Nuclear Medicine Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Nuclear Medicine Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Nuclear Medicine Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Nuclear Medicine Market from 2016 to 2020

    7. North America Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Nuclear Medicine Market Segment by Countries

      • 7.1.1 North America Nuclear Medicine Market Revenue Segment by Countries

      • 7.1.2 North America Nuclear Medicine Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Nuclear Medicine Market Segment (Product Type Level)

    • 7.3 North America Nuclear Medicine Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Nuclear Medicine Market Segment by Countries

      • 8.1.1 Europe Nuclear Medicine Market Revenue Segment by Countries

      • 8.1.2 Europe Nuclear Medicine Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Nuclear Medicine Market Segment (Product Type Level)

    • 8.3 Europe Nuclear Medicine Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Nuclear Medicine Market Segment by Countries

      • 9.1.1 Asia Nuclear Medicine Market Revenue Segment by Countries

      • 9.1.2 Asia Nuclear Medicine Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Nuclear Medicine Market Segment (Product Type Level)

    • 9.3 Asia Nuclear Medicine Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Nuclear Medicine Market Segment by Countries

      • 10.1.1 South America Nuclear Medicine Market Revenue Segment by Countries

      • 10.1.2 South America Nuclear Medicine Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Nuclear Medicine Market Segment (Product Type Level)

    • 10.3 South America Nuclear Medicine Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Nuclear Medicine Market Segment by Countries

      • 11.1.1 Middle East Nuclear Medicine Market Revenue Segment by Countries

      • 11.1.2 Middle East Nuclear Medicine Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Nuclear Medicine Market Segment (Product Type Level)

    • 11.3 Middle East Nuclear Medicine Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Nuclear Medicine Market Segment by Countries

      • 12.1.1 Africa Nuclear Medicine Market Revenue Segment by Countries

      • 12.1.2 Africa Nuclear Medicine Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Nuclear Medicine Market Segment (Product Type Level)

    • 12.3 Africa Nuclear Medicine Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Nuclear Medicine Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Nuclear Medicine Market Segment by Countries

      • 13.1.1 Oceania Nuclear Medicine Market Revenue Segment by Countries

      • 13.1.2 Oceania Nuclear Medicine Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Nuclear Medicine Market Segment (Product Type Level)

    • 13.3 Oceania Nuclear Medicine Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Nuclear Medicine Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Nuclear Medicine

      • 14.2.2 Manufacturing Process Analysis of Nuclear Medicine

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Nuclear Medicine Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Nuclear Medicine Industry Market Status, Pre-COVID-19

      • 15.5.3 Nuclear Medicine Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Nuclear Medicine Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Nuclear Medicine Product Picture

    • Table Nuclear Medicine Product Definition

    • Table Study Scope by Types

    • Figure Global Nuclear Medicine Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Nuclear Medicine Market Value by Application (2016 - 2026)

    • Figure Global Nuclear Medicine Market Size and Growth Rate from 2016 to 2026

    • Table Global Nuclear Medicine Production Capacity by Manufacturers (2016-2021)

    • Table Global Nuclear Medicine Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Nuclear Medicine Revenue by Manufacturers (2016-2021)

    • Table Global Nuclear Medicine Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Nuclear Medicine Plant Distribution and Sales Country

    • Table Yantai Dongcheng Biochemicals - Company Business Overview

    • Figure Yantai Dongcheng Biochemicals Total Revenue from 2018 to 2020

    • Table Yantai Dongcheng Biochemicals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Yantai Dongcheng Biochemicals Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Yantai Dongcheng Biochemicals

    • Table Nuclear Medicine Product Benchmarking

    • Table GE Healthcare - Company Business Overview

    • Figure GE Healthcare Total Revenue from 2018 to 2020

    • Table GE Healthcare Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GE Healthcare Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Nuclear Medicine Product Benchmarking

    • Table Jubilant Pharma - Company Business Overview

    • Figure Jubilant Pharma Total Revenue from 2018 to 2020

    • Table Jubilant Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Jubilant Pharma Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Nuclear Medicine Product Benchmarking

    • Table Eli Lilly - Company Business Overview

    • Figure Eli Lilly Total Revenue from 2018 to 2020

    • Table Eli Lilly Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eli Lilly Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Nuclear Medicine Product Benchmarking

    • Table Mallinckrodt - Company Business Overview

    • Figure Mallinckrodt Total Revenue from 2018 to 2020

    • Table Mallinckrodt Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mallinckrodt Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Nuclear Medicine Product Benchmarking

    • Table China Isotope & Radiation - Company Business Overview

    • Figure China Isotope & Radiation Total Revenue from 2018 to 2020

    • Table China Isotope & Radiation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure China Isotope & Radiation Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Nuclear Medicine Product Benchmarking

    • Table Bracco Imaging - Company Business Overview

    • Figure Bracco Imaging Total Revenue from 2018 to 2020

    • Table Bracco Imaging Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bracco Imaging Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Nuclear Medicine Product Benchmarking

    • Table Nordion - Company Business Overview

    • Figure Nordion Total Revenue from 2018 to 2020

    • Table Nordion Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Nordion Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Nuclear Medicine Product Benchmarking

    • Table Lantheus Medical Imaging - Company Business Overview

    • Figure Lantheus Medical Imaging Total Revenue from 2018 to 2020

    • Table Lantheus Medical Imaging Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lantheus Medical Imaging Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Nuclear Medicine Product Benchmarking

    • Table SIEMENS - Company Business Overview

    • Figure SIEMENS Total Revenue from 2018 to 2020

    • Table SIEMENS Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure SIEMENS Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Nuclear Medicine Product Benchmarking

    • Table Bayer - Company Business Overview

    • Figure Bayer Total Revenue from 2018 to 2020

    • Table Bayer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bayer Sales and Growth Rate Analysis of Nuclear Medicine

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Nuclear Medicine Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Nuclear Medicine Market Revenue by Types (Historical)

    • Table Global Nuclear Medicine Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Tc-99 2016-2021

    • Figure Global Revenue and Growth Rate of I-123/131 2016-2021

    • Figure Global Revenue and Growth Rate of In-111 2016-2021

    • Figure Global Revenue and Growth Rate of Xe-133 2016-2021

    • Figure Global Revenue and Growth Rate of Th-201 2016-2021

    • Figure Global Revenue and Growth Rate of Ga-67 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Nuclear Medicine Market Sales by Types (Historical)

    • Table Global Nuclear Medicine Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Tc-99 2016-2021

    • Figure Global Sales and Growth Rate of I-123/131 2016-2021

    • Figure Global Sales and Growth Rate of In-111 2016-2021

    • Figure Global Sales and Growth Rate of Xe-133 2016-2021

    • Figure Global Sales and Growth Rate of Th-201 2016-2021

    • Figure Global Sales and Growth Rate of Ga-67 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Nuclear Medicine Market Revenue by Types (Forecast)

    • Table Global Nuclear Medicine Market Revenue Market Share by Types (Forecast)

    • Table Global Nuclear Medicine Market Sales by Types (Forecast)

    • Table Global Nuclear Medicine Market Sales Market Share by Types (Forecast)

    • Figure Global Nuclear Medicine Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Nuclear Medicine

    • Table Global Nuclear Medicine Market Revenue by Application (Historical)

    • Table Global Nuclear Medicine Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Diagnostic 2016-2021

    • Figure Global Revenue and Growth Rate of Therapeutic 2016-2021

    • Table Global Nuclear Medicine Market Sales by Application (Historical)

    • Table Global Nuclear Medicine Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Diagnostic 2016-2021

    • Figure Global Sales and Growth Rate of Therapeutic 2016-2021

    • Table Global Nuclear Medicine Market Revenue by Application (Forecast)

    • Table Global Nuclear Medicine Market Revenue Market Share by Application (Forecast)

    • Table Global Nuclear Medicine Market Sales by Application (Forecast)

    • Table Global Nuclear Medicine Market Sales Market Share by Application (Forecast)

    • Table Global Nuclear Medicine Market Revenue by Geography (Historical)

    • Table Global Nuclear Medicine Market Revenue Market Share by Geography (Historical)

    • Figure Global Nuclear Medicine Revenue Market Share by Geography in 2020

    • Table Global Nuclear Medicine Market Sales by Geography (Historical)

    • Table Global Nuclear Medicine Market Sales Market Share by Geography (Historical)

    • Figure Global Nuclear Medicine Sales Market Share by Geography in 2020

    • Table Global Nuclear Medicine Market Revenue by Geography (Forecast)

    • Table Global Nuclear Medicine Market Revenue Market Share by Geography (Forecast)

    • Table Global Nuclear Medicine Market Sales by Geography (Forecast)

    • Table Global Nuclear Medicine Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table North America Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table North America Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table North America Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure North America Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure USA Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure USA Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table North America Nuclear Medicine Sales by Types from 2016 to 2026

    • Table North America Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table North America Nuclear Medicine Value by Types from 2016 to 2026

    • Table North America Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table North America Nuclear Medicine Sales by Application from 2016 to 2026

    • Table North America Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table North America Nuclear Medicine Value by Application from 2016 to 2026

    • Table North America Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Europe Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Europe Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Europe Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Europe Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Germany Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure France Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure France Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Europe Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Europe Nuclear Medicine Value by Types from 2016 to 2026

    • Table Europe Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Europe Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Europe Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Europe Nuclear Medicine Value by Application from 2016 to 2026

    • Table Europe Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Asia Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Asia Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Asia Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Asia Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure China Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure China Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure India Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure India Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Asia Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Asia Nuclear Medicine Value by Types from 2016 to 2026

    • Table Asia Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Asia Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Asia Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Asia Nuclear Medicine Value by Application from 2016 to 2026

    • Table Asia Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table South America Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table South America Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table South America Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table South America Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure South America Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Brazil Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table South America Nuclear Medicine Sales by Types from 2016 to 2026

    • Table South America Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table South America Nuclear Medicine Value by Types from 2016 to 2026

    • Table South America Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table South America Nuclear Medicine Sales by Application from 2016 to 2026

    • Table South America Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table South America Nuclear Medicine Value by Application from 2016 to 2026

    • Table South America Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Middle East Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Middle East Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Middle East Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Middle East Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Middle East Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Middle East Nuclear Medicine Value by Types from 2016 to 2026

    • Table Middle East Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Middle East Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Middle East Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Middle East Nuclear Medicine Value by Application from 2016 to 2026

    • Table Middle East Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Africa Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Africa Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Africa Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Africa Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Nigeria Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Africa Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Africa Nuclear Medicine Value by Types from 2016 to 2026

    • Table Africa Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Africa Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Africa Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Africa Nuclear Medicine Value by Application from 2016 to 2026

    • Table Africa Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Oceania Nuclear Medicine Revenue by Countries from 2016 to 2026

    • Table Oceania Nuclear Medicine Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Nuclear Medicine Revenue Market Share by Major Countries in 2020

    • Table Oceania Nuclear Medicine Sales by Countries from 2016 to 2026

    • Table Oceania Nuclear Medicine Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Nuclear Medicine Sales Market Share by Major Countries in 2020

    • Figure Australia Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Value and Growth Rate from 2016 to 2026

    • Figure Others Nuclear Medicine Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Nuclear Medicine Sales by Types from 2016 to 2026

    • Table Oceania Nuclear Medicine Sales Market Share by Types from 2016 to 2026

    • Table Oceania Nuclear Medicine Value by Types from 2016 to 2026

    • Table Oceania Nuclear Medicine Value Market Share by Types from 2016 to 2026

    • Table Oceania Nuclear Medicine Sales by Application from 2016 to 2026

    • Table Oceania Nuclear Medicine Sales Market Share by Application from 2016 to 2026

    • Table Oceania Nuclear Medicine Value by Application from 2016 to 2026

    • Table Oceania Nuclear Medicine Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Nuclear Medicine

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Nuclear Medicine with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US